The European Commission has approved a diabetes medicine that U.S. regulators have rejected, Reuters reports.
The medication, by Bristol-Myers Squibb Co and AstraZeneca Plc, is called Forxiga. It’s part of a new class of diabetes drugs that work independently of insulin to control blood sugar.
Its manufacturers are touting Forxiga’s capacity for lowering blood pressure and inducing weight loss. But when regulators with the U.S. Food and Drug Administration rejected it in ...
continue reading...
A report in the Philadelphia Inquirer says University of Pennsylvania researchers are using a $1.2 million grant from the National Institutes of Health to create an exhibit about asbestos manufacturing in Ambler, Pa.
The story says Ambler was a company town in the 1880s, dedicated primarily to producing asbestos. At the time, it was considered a viable industry, and it paid off for the residents in terms of affordable housing, a ...
continue reading...
A Baltimore jury awarded a couple $55 million damages, over their claims that Johns Hopkins Hospital’s negligence resulted in their son being born with severe mental and physical disabilities.
A story in the Baltimore Sun says it was one of the largest malpractice judgments in Maryland history.
The mother, Rebecca Fielding, had wanted to deliver her baby at home with the assistance of a midwife, the story ...
continue reading...An article from Pacific News Center concerns a lawsuit that parents of a baby born with severe brain damage filed in District Court of Guam. The parents claim that negligence on the part of the doctor overseeing the birth cause their baby’s disabilities.
The baby’s mother, Shamaralynn Terlaje, alleges in the lawsuit that she experienced prolonged bradycardia – or slowing of the heart rate – three times during her labor.
The lawsuit claims that condition indicated her ...
continue reading...
A Bloomberg story says two relatively new diabetes medicines – Merck’s Januvia and Eli Lilly’s Byetta – don’t work any better than less expensive drugs that were already on the market.
A month’s supply of Januvia costs $163.99, or almost $5.50 a pill, Bloomberg says. And a single cartridge of the injected Byetta costs $200.
The 2007 article cites a review if 29 studies, which found the drugs are no more effective ...
continue reading...
A story in the Greenville News out of South Carolina concerns a local man who filed a lawsuit against the manufacturer of his artificial hip.
The report says Tony R. Bishop had the all-metal M2a Magnum Hip System, manufactured by Indiana-based Biomet, implanted in 2006 after he fell off a horse.
Bishop eventually had it removed last month in a four-hour surgery, after “it caused bone and tissue destruction and toxic levels ...
continue reading...
